Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity
Chemotherapy · 2011 · 57 (4) · 321-326
DOI: 10.1159/000329529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemotherapy, online erschienen am 01.09.2011. Verfasst von Ghada M Suddek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Mansoura University, Egypt. ghmsuddek @ yahoo.com. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Cisplatin is an effective chemotherapeutic agent successfully used in the treatment of a wide range of tumors. Nevertheless, nephrotoxicity has restricted its clinical use. Recent studies have strongly suggested that inflammatory mechanisms may play an important role in the pathogenesis of cisplatin nephrotoxicity. Celecoxib, a selective cyclooxygenase-2 inhibitor used as anti-inflammatory, may therefore have a protective effect on cisplatin-induced renal injury.
Methods
In the present study, rats were injected intraperitoneally with a single dose of cisplatin (7 mg/kg) and/or celecoxib (30 mg/kg) for 5 days.
Results
Nephrotoxicity manifested biochemically by elevations in serum creatinine, blood urea nitrogen, and proteinuria, and an increase in kidney weight as a percentage of total body weight. In addition, a marked decrease in serum albumin was observed. Lipid peroxidation in the kidney was monitored by measuring the malondialdehyde level and glutathione content, which were increased and depleted, respectively. Administration of celecoxib with cisplatin attenuated cisplatin-induced changes in kidney function parameters and oxidative stress markers. Histopathological examination of the kidney confirmed these results.
Conclusion
In conclusion, this study indicates that celecoxib may be a promising drug for clinical use as a nephroprotectant against cisplatin-induced nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Mansoura University, Egypt. ghmsuddek @ yahoo.com
Zitieren
APA
Suddek, G. M., El-Kenawi, A. E., Abdel-Aziz, A., & El-Kashef, H. A. (2011). Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity. Chemotherapy, 57(4), 321-326. https://doi.org/10.1159/000329529
Vancouver
Suddek GM, El-Kenawi AE, Abdel-Aziz A, El-Kashef HA. Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity. Chemotherapy. 2011;57(4):321-326. doi:10.1159/000329529
BibTeX
@article{Suddek2011,
author = {Suddek, Ghada M and El-Kenawi, Asmaa E and Abdel-Aziz, Azza and El-Kashef, Hassan A},
title = {Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity},
journal = {Chemotherapy},
year = {2011},
volume = {57},
number = {4},
pages = {321--326},
doi = {10.1159/000329529}
}
EUVIMED